EN
TR
Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2
Abstract
In drug discovery process the identification of lead compounds by virtual screening is a novel approach. From the literature it is understood that imidazoles and pyrimidines have gained much importance among the medicinal chemists because of their flexible structure and varied pharmacological activities. In present study imidazole and 2-amino pyrimidine derivatives were designed, subjected to the structure based virtual screenings in order to find the novel anticancer agents against human CDK2 protein. The molecular properties and molecular toxicity prediction was done using various online softwares like Molinspiration, Molsoft, OSIRIS, pkCSM along with bioactivity properties. The derivatives which exhibited drug like property were further subjected to molecular docking studies using Autodock Vina. Hits are identified, the basic pharmacophoric features responsible for the anticancer activity were predicted. Based on docking results the compound 24, which exhibited highest binding interaction with receptor will be further synthesized and can be novel lead for the development of anticancer agents.
Keywords
References
- Dr. Y. Rajendra Prasad Principal, Pharmaceutical Sciences, Andhra University, Vishakapatnam, Andhra Pradesh. mail. id: dryrp_au@rediffmail.com
Details
Primary Language
English
Subjects
Pharmacology and Pharmaceutical Sciences
Journal Section
Research Article
Authors
Publication Date
December 1, 2023
Submission Date
September 20, 2022
Acceptance Date
June 20, 2023
Published in Issue
Year 2023 Volume: 43 Number: 4
APA
Oleti, N., Sunkara, M. S., Kurella, P., Manchı, S., & Sattu, H. (2023). Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. Hacettepe University Journal of the Faculty of Pharmacy, 43(4), 285-300. https://doi.org/10.52794/hujpharm.1177687
AMA
1.Oleti N, Sunkara MS, Kurella P, Manchı S, Sattu H. Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. HUJPHARM. 2023;43(4):285-300. doi:10.52794/hujpharm.1177687
Chicago
Oleti, Navneetha, Munı Sıreesha Sunkara, Pranitha Kurella, Sahithi Manchı, and Hemalatha Sattu. 2023. “Novel Imidazole 2-Amino Pyrimidine Deivatives: Insilico Studies, Evaluation of Their Anti-Cancer Activity Against Human-CDK2”. Hacettepe University Journal of the Faculty of Pharmacy 43 (4): 285-300. https://doi.org/10.52794/hujpharm.1177687.
EndNote
Oleti N, Sunkara MS, Kurella P, Manchı S, Sattu H (December 1, 2023) Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. Hacettepe University Journal of the Faculty of Pharmacy 43 4 285–300.
IEEE
[1]N. Oleti, M. S. Sunkara, P. Kurella, S. Manchı, and H. Sattu, “Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2”, HUJPHARM, vol. 43, no. 4, pp. 285–300, Dec. 2023, doi: 10.52794/hujpharm.1177687.
ISNAD
Oleti, Navneetha - Sunkara, Munı Sıreesha - Kurella, Pranitha - Manchı, Sahithi - Sattu, Hemalatha. “Novel Imidazole 2-Amino Pyrimidine Deivatives: Insilico Studies, Evaluation of Their Anti-Cancer Activity Against Human-CDK2”. Hacettepe University Journal of the Faculty of Pharmacy 43/4 (December 1, 2023): 285-300. https://doi.org/10.52794/hujpharm.1177687.
JAMA
1.Oleti N, Sunkara MS, Kurella P, Manchı S, Sattu H. Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. HUJPHARM. 2023;43:285–300.
MLA
Oleti, Navneetha, et al. “Novel Imidazole 2-Amino Pyrimidine Deivatives: Insilico Studies, Evaluation of Their Anti-Cancer Activity Against Human-CDK2”. Hacettepe University Journal of the Faculty of Pharmacy, vol. 43, no. 4, Dec. 2023, pp. 285-00, doi:10.52794/hujpharm.1177687.
Vancouver
1.Navneetha Oleti, Munı Sıreesha Sunkara, Pranitha Kurella, Sahithi Manchı, Hemalatha Sattu. Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. HUJPHARM. 2023 Dec. 1;43(4):285-300. doi:10.52794/hujpharm.1177687